NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia

被引:53
作者
Falini, Brunangelo [1 ]
Mecucci, Cristina [1 ]
Saglio, Giuseppe [2 ]
Lo Coco, Francesco [3 ]
Diverio, Daniela [4 ]
Brown, Patrick [5 ]
Pane, Fabrizio [6 ]
Mancini, Marco [4 ]
Martelli, Maria Paola [1 ]
Pileri, Stefano [7 ]
Haferlach, Torsten [8 ]
Haferlach, Claudia [8 ]
Schnittger, Susanne [8 ]
机构
[1] Univ Perugia, Inst Hematol, Perugia, Italy
[2] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Turin, Italy
[3] Policlin Tor Vergata, Dept Biopathol & Diagnost Imaging, Rome, Italy
[4] Policlin La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
[5] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[6] Univ Federico II, Dept Biochem & Med Biotechnol, Neples, Italy
[7] Univ Bologna, Policlin S Orsola, Lab Hematopathol, Bologna, Italy
[8] Munich Leukemia Lab GmbH, Munich, Germany
关键词
acute myeloid leukemia; nucleophosmin; NPM; mutations; antibodies; immunohistochemistry;
D O I
10.3324/haematol.12153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute myeloid leukemia carrying NPM1 mutations and cytoplasmic nucleophosmin (NPMc(+) acute myeloid leukemia) represents one-third of adult AML (50-60% of all acute myeloid leukemia with normal karyotype) and shows distinct biological, pathological and clinical features. We confirm in 2562 patients with acute myeloid leukemia our previous observation that NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities. Taken together, these findings make NPMc+ acute myeloid leukemia a good candidate for inclusion in the upcoming World Health Organization classification.
引用
收藏
页码:439 / 442
页数:4
相关论文
共 22 条
[1]   Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance [J].
Alcalay, M ;
Tiacci, E ;
Bergomas, R ;
Bigerna, B ;
Venturini, E ;
Minardi, SP ;
Meani, N ;
Diverio, D ;
Bernard, L ;
Tizzoni, L ;
Volorio, S ;
Luzi, L ;
Colombo, E ;
Lo Coco, F ;
Mecucci, C ;
Falini, B ;
Pelicci, PG .
BLOOD, 2005, 106 (03) :899-902
[2]   Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants [J].
Bolli, Niccolo ;
Nicoletti, Ildo ;
De Marco, M. Felicetta ;
Bigerna, Barbara ;
Pucciarini, Alessandra ;
Mannucci, Roberta ;
Martelli, Maria Paola ;
Liso, Arcangelo ;
Mecucci, Cristina ;
Fabbiano, Francesco ;
Martelli, Massimo F. ;
Henderson, Beric R. ;
Falini, Brunangelo .
CANCER RESEARCH, 2007, 67 (13) :6230-6237
[3]   Simultaneous PML/RARα and AML1/ETO expression with t(15;17) at onset and relapse with only t(8;21) in an acute promyelocytic leukemia patient [J].
Bonomi, R ;
Giordano, H ;
Moreno, MD ;
Bodega, E ;
Landoni, AI ;
Gallagher, R ;
Uriarte, MD .
CANCER GENETICS AND CYTOGENETICS, 2000, 123 (01) :41-43
[4]   Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].
Falini, B ;
Mecucci, C ;
Tiacci, E ;
Alcalay, M ;
Rosati, R ;
Pasqualucci, L ;
La Starza, R ;
Diverio, D ;
Colombo, E ;
Santucci, A ;
Bigerna, B ;
Pacini, R ;
Pucciarini, A ;
Liso, A ;
Vignetti, M ;
Fazi, P ;
Meani, N ;
Pettirossi, V ;
Saglio, G ;
Mandelli, F ;
Lo-Coco, F ;
Pelicci, P ;
Martelli, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266
[5]   Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias [J].
Falini, Brunangelo ;
Nicoletti, Ildo ;
Bolli, Niccolo ;
Martelli, Maria Paola ;
Liso, Arcangelo ;
Gorello, Paolo ;
Mandelli, Franco ;
Mecucci, Cristina ;
Martelli, Massimo Fabrizio .
HAEMATOLOGICA, 2007, 92 (04) :519-532
[6]   Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features [J].
Falini, Brunangelo ;
Nicoletti, Ildo ;
Martelli, Massimo F. ;
Mecucci, Cristina .
BLOOD, 2007, 109 (03) :874-885
[7]   Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia [J].
Falini, Brunangelo ;
Martelli, Maria Paola ;
Bolli, Niccolo ;
Bonasso, Rossella ;
Ghia, Emanuela ;
Pallotta, Maria Teresa ;
Diverio, Daniela ;
Nicoletti, Ildo ;
Pacini, Roberta ;
Tabarrini, Alessia ;
Galletti, Barbara Verducci ;
Mannucci, Roberta ;
Roti, Giovanni ;
Rosati, Roberto ;
Specchia, Giorgina ;
Liso, Arcangelo ;
Tiacci, Enrico ;
Alcalay, Myriam ;
Luzi, Lucilla ;
Volorio, Sara ;
Bernard, Loris ;
Guarini, Anna ;
Amadori, Sergio ;
Mandelli, Franco ;
Pane, Fabrizio ;
Lo-Coco, Francesco ;
Saglio, Giuseppe ;
Pelicci, Pier-Giuseppe ;
Martelli, Massimo F. ;
Mecucci, Cristina .
BLOOD, 2006, 108 (06) :1999-2005
[8]   Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML [J].
Falini, Brunangelo ;
Bolli, Niccolò ;
Shan, Jing ;
Martelli, Maria Paola ;
Liso, Arcangelo ;
Pucciarini, Alessandra ;
Bigerna, Barbara ;
Pasqualucci, Laura ;
Mannucci, Roberta ;
Rosati, Roberto ;
Gorello, Paolo ;
Diverio, Daniela ;
Roti, Giovanni ;
Tiacci, Enrico ;
Cazzaniça, Giovanni ;
Biondi, Andrea ;
Schnittger, Suzanne ;
Haferlach, Torsten ;
Hiddemann, Wolfgang ;
Martelli, Massimo F. ;
Gu, Wei ;
Mecucci, Cristina ;
Nicoletti, Ildo .
BLOOD, 2006, 107 (11) :4514-4523
[9]   Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation [J].
Hussein, Kais ;
Bock, Oliver ;
Seegers, Anna ;
Flasshove, Michael ;
Henneke, Felicitas ;
Buesche, Guntram ;
Kreipe, Hans Heinrich .
BLOOD, 2007, 109 (09) :4106-4107
[10]   JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia [J].
Kraemer, Alwin ;
Reiter, Andreas ;
Kruth, Jens ;
Erben, Philipp ;
Hochhaus, Andreas ;
Mueller, Martin ;
Cross, Nicholas C. P. ;
Jones, Amy V. ;
Ho, Anthony D. ;
Hensel, Manfred .
LANCET ONCOLOGY, 2007, 8 (07) :658-660